S

Stryker

Manufactures orthopedic and surgical medical devices

Regional Sales Manager - Trauma Product Portfolio

Full-Time
€87.1k - €145.2k/yr+ Bonus + Commission
Senior
Bachelor's
Mons, Belgium+10 moreMore locations: Aalst, Belgium | Namur, Belgium | Bruges, Belgium | Brussels, Belgium | Charleroi, Belgium | Ghent, Belgium | Hasselt, Belgium | Kortrijk, Belgium | Antwerp, Belgium | Liège, Belgium
In PersonField-based role requiring travel throughout the region.
Sales & Account ManagementField Sales

About the job

Requirements
  • A degree or equivalent is required.
  • At least five years of successful sales and/or marketing experience with demonstrable examples of leading others, ideally in MedTech, Biotech, Pharma, Healthcare, or a related industry.
  • Experience leading, coaching, mentoring, or influencing others, with a track record of developing talent.
  • Proficiency in English and either Dutch or French is required; proficiency in both Dutch and French is an advantage.
  • Demonstrated success in achieving and exceeding sales targets and business objectives.
  • Experience managing complex sales cycles involving multiple stakeholders and decision-makers.
  • Strategic thinking and strong business acumen, including the ability to analyze sales performance data and identify growth opportunities.
  • Experience in territory planning, forecasting, and pipeline management.
  • Strong problem-solving skills and the ability to act as an escalation point for team members and customers.
  • Excellent communication, negotiation, collaboration, and interpersonal skills.
  • Ability to influence internal and external stakeholders.
  • Proficiency in customer relationship management systems and Microsoft Office.
  • Ability to manage multiple priorities and deliver results in a dynamic environment.
  • A valid driver's license and flexibility to travel in the region are required because the position involves customer interactions in the field.
Responsibilities
  • Learn the portfolio and build relationships with internal and external stakeholders during an initial familiarization phase.
  • Execute the commercial strategy for the assigned region by translating business objectives into actionable plans that deliver sales growth and financial commitments.
  • Deliver regional sales targets through effective territory management, sales planning, and customer engagement.
  • Provide accurate sales forecasts and maintain a healthy sales pipeline.
  • Lead the team to achieve high engagement and performance, driving accountability and business results.
  • Attract, develop, engage, and retain talent through coaching, performance management, and succession planning.
  • Set clear expectations, provide regular feedback, and recognize strong performance to develop people.
  • Model the company's values and leadership expectations while ensuring compliance with company policies, procedures, and ethical standards.
  • Build and maintain customer relationships to retain and grow the business.
  • Partner with Marketing, Finance, Customer Service, and other enabling functions to execute business priorities and support customer success.
  • Monitor market trends, competitive activity, customer needs, and growth opportunities, and provide insights and recommendations to support business decisions and regional performance.
  • Lead regional sales and marketing initiatives to drive market share growth.
  • Support change initiatives that simplify, scale, and innovate work practices.
  • Collaborate with peers across regions and divisions to share best practices and drive cross-divisional success.
  • Build a network with key customers, decision-makers, key opinion leaders, and internal stakeholders.
Desired Qualifications
  • Knowledge of orthopaedics or anatomy is advantageous but not mandatory.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 21st, 2026
P&G and Stryker: two dividend stocks to hold for decades

Procter & Gamble and Stryker are two dividend stocks suited to long-term holders, according to the article. Both sell products people need in any economy. P&G has raised its dividend for 70 consecutive years. In fiscal 2026, it posted net sales of about $87 billion, up 3%, and net earnings of $16.1 billion. It returned more than $15 billion to shareholders, including $10.2 billion in dividends. Organic sales and core earnings per share each grew just 1%. Stryker has raised its dividend for more than three decades. Second-quarter 2026 revenue rose 9.4% to $6.6 billion, and adjusted earnings per share climbed 17.9% to $3.69. Demand should gain from an ageing US population, though recalls, acquisition costs, and hospital spending pressures remain risks.

Yahoo Finance
Oct 14th, 2026
Stryker wins FDA clearance for Sonopet 3 ultrasonic bone and tissue removal platform

Stryker has received US Food and Drug Administration (FDA) 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The company announced the news on October 14, 2026. Stryker developed the platform with input from hundreds of surgeons. It offers more power, precision and versatility, along with two technologies: RISE, which connects the surgical workflow, and Pulse Control, which helps regulate the resection of hard and soft tissues. "They told us they wanted more power, improved ergonomics and enhanced integration," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. The first clinical cases are expected to begin in October. A full commercial launch is planned for later this fall.

Yahoo Finance
Oct 12th, 2026
Stryker shares fall 20% in six months despite 9.2% organic growth and $25.84B revenue

Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.

Seeking Alpha
Oct 12th, 2026
Stryker to invest $400M in CMR Surgical, with option to buy the robotics maker outright

Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.

PR Newswire
Oct 5th, 2026
Stryker launches Mako 4 SmartRobotics in India after 2.5M procedures globally

Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.